Klinische Monatsblatter fur Augenheilkunde最新文献

[Cystoid macular edema (CME) and immune responses after DMEK/Triple DMEK: Real-life data from Oregis]. [膀胱样黄斑水肿（CME）和DMEK/三重DMEK后的免疫反应：来自俄勒冈州的真实数据]。

IF 0.8 4区医学

Klinische Monatsblatter fur Augenheilkunde Pub Date : 2025-07-08 DOI: 10.1055/a-2650-9712

Johanna Wiedemann, Christopher Dicke, Björn O Bachmann, Lebriz Altay, Claus Cursiefen

引用次数: 0

[Orbital floor fractures in Germany: Interdisciplinary care without a uniform standard - results of a multicenter survey]. [德国眶底骨折：缺乏统一标准的跨学科治疗-多中心调查结果]。

IF 0.8 4区医学

Klinische Monatsblatter fur Augenheilkunde Pub Date : 2025-06-24 DOI: 10.1055/a-2642-2470

Christoph Holtmann, Mathias Roth, Gesine Szurman, Ulrike Grenzebach, Norbert Schrage, Christian Brinkmann, Bettina Wabbels, Burkhard Dick, Markus Kohlhaas, Gernot Freißler, Marc Schargus, Lutz Hesse, Johann Roider, Agata Anna Wykrota, Arthur Müller, Gangolf Sauder, Frank Tost, Jürgen Walther, Andreas Scheider, Mathias M Maier, Kathi Hartmann, Eckart Bertelmann, Christoph Hintschich, Markus Ladewig, Anja Eckstein, Thomas Reinhard, Michael P Schittkowski, Alexander C Rokohl, Ludwig Maximilian Heindl, Ina Sterker, Salvatore Grisanti, Giulia Renieri, Heike Maria Elflein, Tobias Brockmann, Patrizia Krauss, Karsten Hufendiek, Volker Besgen, Katja Ruediger, Jens Heichel, Arne Viestenz, Maria Borrelli, Gerd Geerling

引用次数: 0

Spontaneous Closure of Full-Thickness Macular Hole in a Patient with Retinal Arteriovenous Malformation: Sixteen-Year Follow-up. 视网膜动静脉畸形患者全层黄斑孔自动闭合：16年随访。

IF 0.8 4区医学

Klinische Monatsblatter fur Augenheilkunde Pub Date : 2025-06-16 DOI: 10.1055/a-2550-0839

Zeynep Serikoglu Akbas, Faik Gelisken, Benedikt Rössler

引用次数: 0

Tendon Elongation with Fascia Lata Grafts in Strabismus Surgery - Multiple Indications Apart from Graves' Orbitopathy. 斜视手术中阔筋膜肌腱伸长术-除Graves眼病外的多种适应症。

IF 0.8 4区医学

Klinische Monatsblatter fur Augenheilkunde Pub Date : 2025-06-16 DOI: 10.1055/a-2611-2250

Julia Prinz, Kathi Hartmann, Peter Walter, Tibor Lohmann, Matthias Fuest, David Kuerten

{"title":"Tendon Elongation with Fascia Lata Grafts in Strabismus Surgery - Multiple Indications Apart from Graves' Orbitopathy.","authors":"Julia Prinz, Kathi Hartmann, Peter Walter, Tibor Lohmann, Matthias Fuest, David Kuerten","doi":"10.1055/a-2611-2250","DOIUrl":"https://doi.org/10.1055/a-2611-2250","url":null,"abstract":"Background: To investigate the use of fascia lata (FL) grafts for eye muscle tendon elongation in patients with complex and residual strabismus types apart from Graves' orbitopathy.Methods and materials: In this retrospective study, a heterogeneous group of 27 eyes of 21 patients with complex and residual strabismus types who underwent elongation of the eye muscle tendon with FL were included. Orthoptic and ophthalmological examinations including measurement of the head posture, the extent of deviation in primary position (PP), and monocular excursion were conducted preoperatively and after a mean postoperative time of 12.2 (6.0 - 37.0, median 7.0) months in all patients.Results: Eight patients (12 eyes) with residual exotropia, 4 patients (4 eyes) with residual esotropia, 4 patients (6 eyes) with partial abducens nerve palsy, 4 patients (4 eyes) with vertical deviation, and 1 patient (1 eye) with Duane's retraction syndrome (DRS) type I were included. A residual squint angle of 10Δ or less was achieved in 57.1% of the patients at the last follow-up. The head posture was significantly reduced at the last follow-up compared to preoperatively in patients with residual exotropia (p = 0.002), esotropia (p = 0.040), abducens nerve palsy (p = 0.005), and vertical deviation (p = 0.005). At the last follow-up, a significant reduction in the squint angle occurred in patients with residual exotropia (p = 0.001), abducens nerve palsy (p = 0.046), and vertical deviation (p = 0.033).Conclusion: FL grafts may offer safe and effective surgical options for complex and residual strabismus types. No significant reduction in the excursion into the fields of action of the affected muscles was witnessed.","PeriodicalId":17904,"journal":{"name":"Klinische Monatsblatter fur Augenheilkunde","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144310115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Recurrent Exposure of the PRESERFLO MicroShunt Implant. Preserflo Microshunt 植入物反复暴露。

IF 0.8 4区医学

Klinische Monatsblatter fur Augenheilkunde Pub Date : 2025-06-13 DOI: 10.1055/a-2250-9841

Lara Borrego Sanz, Carmen Dora Méndez Hernández, Fernado Ly Yang, Verónica Gómez Calleja, Federico Sáenz-Francés San Baldomero

引用次数: 0

Real-world Efficacy, Safety, and the Impact of Spherical Equivalent on Intravitreal Anti-VEGF Therapy in Patients Affected by Myopic Choroidal Neovascularisation. 在近视脉络膜新生血管患者中，球形等效物对玻璃体内抗vegf治疗的实际疗效、安全性和影响。

IF 0.8 4区医学

Klinische Monatsblatter fur Augenheilkunde Pub Date : 2025-06-11 DOI: 10.1055/a-2561-2847

Peter Wolfrum, Anna Maria Voigt, Katrin Lorenz, Bernhard M Stoffelns, Christina A Korb

{"title":"Real-world Efficacy, Safety, and the Impact of Spherical Equivalent on Intravitreal Anti-VEGF Therapy in Patients Affected by Myopic Choroidal Neovascularisation.","authors":"Peter Wolfrum, Anna Maria Voigt, Katrin Lorenz, Bernhard M Stoffelns, Christina A Korb","doi":"10.1055/a-2561-2847","DOIUrl":"https://doi.org/10.1055/a-2561-2847","url":null,"abstract":"Purpose: To analyse real-world clinical outcomes and influence of the spherical equivalent (SE) on anti-vascular endothelial growth factor (VEGF) therapy in patients affected by myopic choroidal neovascularisation (mCNV).Patients and methods: A retrospective investigation was conducted on treatment-naïve mCNV patients receiving anti-VEGF therapy at the Department of Ophthalmology, University Medical Center Mainz, Germany, between January 2018 and March 2024. Safety, functional and morphological changes in visual acuity (VA), central retinal thickness (CRT), and central retinal volume (CRV) were evaluated over a two-year period. Further, we analysed how baseline VA and CRT relate to it's final outcome measures. Finally, a subgroup analysis assessed the impact of SE above and below - 10 D.Results: Significant improvements in VA, CRT, and CRV were observed. VA improved from 0.5 ± 0.27 logMAR to 0.38 ± 0.31 logMAR (p = 0.005) at 6 months and remained stable at 2 years. CRT and CRV decreased from 344.4 ± 115.0 µm to 284.2 ± 45.2 µm (p < 0.001) and 0.27 ± 0.09 mm³ to 0.22 ± 0.04 mm³ (p < 0.001), respectively, four weeks after the initial injection, with stability maintained thereafter. Baseline VA correlated strongly with final VA, whereas CRT did not. No adverse events were reported. The subgroup analysis showed no significant outcome differences based on SE.Conclusion: Anti-VEGF therapy in mCNV patients proved to be safe and effective in our study with sustained improvement in functional and anatomical measures. Baseline VA strongly predicted final VA, whereas baseline and final CRT showed no association. No differences in treatment outcomes were observed as based on a varying SE.","PeriodicalId":17904,"journal":{"name":"Klinische Monatsblatter fur Augenheilkunde","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-06-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144275276","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

[Phlyctenular Conjunctivitis and Enterohaemorrhagic Escherichia coli Infection]. [静脉性结膜炎和肠出血性大肠杆菌感染]。

IF 0.8 4区医学

Klinische Monatsblatter fur Augenheilkunde Pub Date : 2025-06-11 DOI: 10.1055/a-2611-2362

Silvia Reichart, Matus Rehak, Wolfgang J Behrens-Baumann

引用次数: 0

A Rare Case of CLN3-associated Isolated Retinal Degeneration with Macular Oedema. 罕见的cln3相关性孤立性视网膜变性伴黄斑水肿1例。

IF 0.8 4区医学

Klinische Monatsblatter fur Augenheilkunde Pub Date : 2025-06-03 DOI: 10.1055/a-2577-9808

Dimitrios Kalogeropoulos, Samir Khandhadia, Fatima Shawkat, Andrew John Lotery

引用次数: 0

[Foveal Red Spot Syndrome - Diagnosis on Sight?] 中央凹红斑综合征-视觉诊断？］

IF 0.8 4区医学

Klinische Monatsblatter fur Augenheilkunde Pub Date : 2025-06-03 DOI: 10.1055/a-2604-4288

Niklas Schön, Patrick K Peschke, Warda Darwisch, Clara Eileen Englisch, Annekatrin Rickmann

引用次数: 0

Artificial Intelligence for the Detection of Diabetic Retinopathy. 糖尿病视网膜病变的人工智能检测。

IF 0.8 4区医学

Klinische Monatsblatter fur Augenheilkunde Pub Date : 2025-06-02 DOI: 10.1055/a-2545-1192

Ansgar Beuse, Carsten Grohmann, Hauke M Schadwinkel, Christos Skevas, Martin S Spitzer

{"title":"Artificial Intelligence for the Detection of Diabetic Retinopathy.","authors":"Ansgar Beuse, Carsten Grohmann, Hauke M Schadwinkel, Christos Skevas, Martin S Spitzer","doi":"10.1055/a-2545-1192","DOIUrl":"https://doi.org/10.1055/a-2545-1192","url":null,"abstract":"Screening and timely treatment can avoid the majority of severe vision loss and blindness from diabetic retinopathy. Artificial intelligence (AI) algorithms that detect DR from retinal photographs without human assessment might reduce the challenges of systematic screening. The German National Care Guideline recommends that individuals with diabetes receive annual or biennial eye examinations to detect treatable DR. Efficient and comprehensive screening of the growing diabetic population requires more and more resources. Artificial intelligence (AI) algorithms that detect DR from retinal photographs without human assessment might help in coping with the immense screening burden. Many of these AI algorithms have achieved good sensitivity and specificity for detecting treatable DR, as compared to human graders; however, many important challenges remain, such as acceptance, cost-effectiveness, liability issues, IT security, and reimbursement. AI-supported DR screening has so far only been used to a limited extent, even in countries with a developed digital infrastructure. These questions must be addressed before AI-based DR screening can be implemented on a large scale into clinical practice. This overview presents key concepts in development and currently approved AI applications for DR screening.","PeriodicalId":17904,"journal":{"name":"Klinische Monatsblatter fur Augenheilkunde","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144208900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0